Viewing Study NCT00925106


Ignite Creation Date: 2025-12-26 @ 10:59 AM
Ignite Modification Date: 2026-05-18 @ 12:58 PM
Study NCT ID: NCT00925106
Status: COMPLETED
Last Update Posted: 2021-02-02
First Post: 2009-06-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics Of Celecoxib Test Formulations
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A3191355
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators